| Literature DB >> 32135038 |
Hyeok-Won Lee1, Jung-Ho Park2, Won-Kyo Kim1, Jin-Gyeom Lee1, Ju-Seok Lee2, Jung-Oh Ahn1,3, Eun-Gyo Lee1,3, Hong-Weon Lee1,3.
Abstract
Volatile compounds can be produced by fermentation from genetically engineered microorganisms. Escherichia coli strains are mainly used for isoprene production owing to their higher titers; however, this has thus far been confined to only strains BL21, BL21 (DE3), Rosetta, and BW25113. Here, we tested four groups of E. coli strains for improved isoprene production, including K-12 (DH5α, BW25113, W3110, MG1655, XL1-Blue, and JM109), B [Rosetta (DE3), BL21, and BL21 (DE3)], Crooks C, and Waksman W strains. The isoprene productivity of BL21 and MG1655 was remarkably higher than that of the others in 5-L fermentation, and scale-up fermentation (300 L) of BL21 was successfully performed. This system shows potential for biobased production of fuel and volatile compounds in industrial applications.Entities:
Keywords: Escherichia coli strains; fermentation; isoprene production; scale-up
Mesh:
Substances:
Year: 2020 PMID: 32135038 PMCID: PMC7193156 DOI: 10.1002/2211-5463.12829
Source DB: PubMed Journal: FEBS Open Bio ISSN: 2211-5463 Impact factor: 2.693
Escherichia coli strains and plasmids used in the study.
|
| Genotype or description | Derivation | References |
|---|---|---|---|
| Strains | |||
| DH5α |
F–
Δ( | K‐12 | |
| BW25113 | F−, DE(araD‐araB)567, lacZ4787(del)::rrnB‐3, LAM−, rph‐1, DE(rhaD‐rhaB)568, hsdR514 | K‐12 | |
| W3110 | F− λ− rph‐1 INV(rrnD, rrnE) | K‐12 | |
| MG1655 | K‐12 F– λ–
| K‐12 | |
| XL1‐Blue |
endA1 gyrA96(nalR) thi‐1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK − mK +) | K‐12 | |
| JM109 |
endA1 glnV44 thi‐1 relA1 gyrA96 recA1 mcrB+ Δ(lac‐proAB) e14‐ [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK −mK +) | K‐12 | |
| Rosetta (DE3) |
F–
pLysSRARE[ | B | |
| BL21 | F‐ dcm ompT hsdS(rB‐ mB‐) gal [malB+]K‐12(λS) | B | |
| BL21 (DE3) | F–
| B | |
| Crooks strain C | Wild‐type | C | |
| Waksman strain W | Wild‐type | W | |
| Plasmids | |||
| pTS‐sPt‐MVA |
pTrc99K containing
| pTrc99A | [ |
| pS‐NA |
pSTV28 containing
| pSTV28 | [ |
Fig. 1Time course of (A) cell mass, (B) glycerol consumption, (C) isoprene concentration, (D) lactate concentration, and (E) acetate concentration during 5‐L batch fermentation of recombinant Escherichia coli strains harboring pTS‐sPT‐MVA.
Results of batch cultivation by four types of Escherichia coli strains.
| Strains | Culture time (h) | Consumed glycerol (g·L−1) | Specific growth rate (μmax) |
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|
| K‐12 | DH5α | 28 | 54 | 0.59 | 20.40 ± 0.12 | 1.45 ± 0.18 | 51.67 | 70.92 | 26.79 |
| BW25113 | 26 | 53 | 0.35 | 15.99 ± 0.08 | 1.41 ± 0.12 | 54.10 | 87.97 | 26.54 | |
| W3110 | 23 | 52 | 0.79 | 22.05 ± 0.30 | 2.24 ± 0.07 | 97.39 | 101.59 | 43.08 | |
| MG1655 | 25 | 52.6 | 0.40 | 19.65 ± 0.06 | 3.90 ± 0.32 | 156.00 | 198.47 | 74.14 | |
| XL1‐Blue | 25 | 49.1 | 0.44 | 14.37 ± 0.16 | 2.02 ± 0.25 | 80.80 | 140.57 | 41.14 | |
| JM109 | 21 | 51.6 | 0.72 | 13.35 ± 0.32 | 0.82 ± 0.19 | 39.05 | 61.42 | 15.89 | |
| B | Rosetta (DE3) | 28 | 49.05 | 0.30 | 13.80 ± 0.28 | 0.96 ± 0.32 | 34.29 | 69.57 | 19.57 |
| BL21 | 25 | 55.8 | 0.46 | 14.37 ± 0.22 | 4.84 ± 0.20 | 193.60 | 336.81 | 86.74 | |
| BL21 (DE3) | 21 | 49 | 0.37 | 17.22 ± 0.16 | 1.51 ± 0.07 | 72.06 | 87.88 | 30.88 | |
| C |
| 22 | 52.8 | 0.76 | 17.64 ± 0.03 | 0.61 ± 0.14 | 27.88 | 34.77 | 11.62 |
| W |
| 20 | 50.92 | 0.77 | 20.73 ± 0.15 | 2.09 ± 0.06 | 104.67 | 100.98 | 41.11 |
Data are mean ± SD; n = 3 per strain.
Results of fed‐batch cultivation by Escherichia coli MG1655 and BL21.
| Strains | Culture type | Culture time (h) | Consumed glycerol (g·L−1) | Specific growth rate (μmax) |
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| MG1655 harboring pTS‐sPT‐MVA | 5 L | 54 | 181 | 0.45 | 43.5 ± 0.28 | 7.32 ± 0.09 | 135.55 | 168.27 | 40.44 |
| BL21 harboring pTS‐sPT‐MVA | 5 L | 54 | 161 | 0.48 | 45.3 ± 0.32 | 11.38 ± 0.16 | 210.74 | 251.21 | 70.68 |
| MG1655 harboring pTS‐sPT‐MVA and pS‐NA | 5 L | 54 | 223 | 0.49 | 56.7 ± 0.13 | 19.16 ± 0.38 | 354.81 | 337.91 | 85.91 |
| BL21 harboring pTS‐sPT‐MVA and pS‐NA | 5 L | 54 | 198 | 0.44 | 49.8 ± 0.08 | 22.29 ± 0.24 | 412.77 | 447.59 | 112.57 |
| BL21 harboring pTS‐sPT‐MVA and pS‐NA | 300 L | 72 | 241 | 0.53 | 33.6 ± 0.17 | 25.2 ± 0.15 | 350 | 750 | 104.56 |
Data are mean ± SD; n = 3 per strain.
Fig. 2Time course of (A) Escherichia coli MG1655 harboring pTS‐sPT‐MVA, (B) E. coli MG1655 harboring pTS‐sPT‐MVA and pS‐NA, (C) E. coli BL21 harboring pTS‐sPT‐MVA, (D) and E. coli BL21 harboring pTS‐sPT‐MVA and pS‐NA during 5‐L fed‐batch fermentation.
Fig. 3Time course of 300‐L fed‐batch cultivation of Escherichia coli BL21 harboring pTS‐sPT‐MVA and pS‐NA.